Document is current

Article History

Accepted: 22 May 2022

First Online: 30 September 2022

Declarations

:

: Medical writing and editorial support were provided by Emily Clark of OPEN Health Communications, London, UK, with financial support from Bayer.

: Jean-Yves Blay has received advisory/consultancy fees from Bayer, Roche, Deciphera, Bristol-Myers Squibbs, Merck Sharpe & Dohme, and Pharmamar. Jean-Yves Blay has received speaker honoraria from Bayer, Roche, Pharmamar, and Deciphera. Jean-Yves Blay has received research grants or funding from Bayer, Roche, Deciphera, Bristol-Myers Squibbs, Merck Sharpe & Dohme, Pharmamar, Novartis, and GlaxoSmithKline. Florence Duffaud has received advisory/consultancy fees from Bayer, Pharmamar, GlaxoSmithKline, and Deciphera. Florence Duffaud has given a sponsored lecture and received speaker honoraria from Pharmamar and has received research grants or funding from Bayer. Suzanne George owns stock in Abbott Laboratories. Suzanne George has received speaker honoraria from C-Stone. Suzanne George has received advisory/consultancy fees from Blueprint Medicines, Deciphera, Bayer, Lilly, UpToDate, Research to Practise, MORE Health, Daiichi, Kayothera, and Immunicum. Suzanne George has received research grants or funding from Blueprint Medicines, Deciphera, Daiichi Sankyo RD Novare, Merck, Eisai, Springworks Therapeutics, TRACON Pharma, and Theseus Pharmaceuticals. Suzanne George holds patents, royalties, or other intellectual property with UptoDate. Suzanne George has given expert testimony for Bayer. Robert G. Maki has received speaker honoraria or advisory/consultancy fees from AADi, Bayer, BioAlta, Decipehra, Immune Design, Karyopharm, Presage, Springworks, American Board of Internal Medicine, American Society for Clinical Oncology, and UptoDate. Robert G. Maki has received research grants or funding from Amgen, Astex, Bayer, BioAlta, Boeringer Ingleheim, Exelixis, Genentech, Karyopharm, Presage, Rain, Springworks, Synox, and TRACON Pharma. Robert G. Maki has received travel expenses from Bayer and Tracon. Nicolas Penel has received research grants or funding from Bayer.

: This article does not contain any studies with human or animal subjects performed by any of the authors.